PD-1/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice. Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, et al. Clin Cancer Res 2020 Apr 30. pii: 1078-0432.CCR-20-0798.

Read + Share

Amedeo Smart

Independent Medical Education

Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, et al. PD-1/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice. Clin Cancer Res 2020 Apr 30. pii: 1078-0432.CCR-20-0798.
PMID: 32354698